Harmony Biosciences Holdings (HRMY) support and resistance · P/E 14, rev $476.7M
Harmony Biosciences Holdings (HRMY) is a biotechnology company listed on NASDAQ.
This page maps Harmony Biosciences Holdings (HRMY) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported HRMY revenue for 2026-06-30 was $476.7M. Net income was $107.9M. HRMY currently screens at market cap $1.96B and trailing P/E 13.6.
HRMY currently screens at market cap $1.96B and trailing P/E 13.6. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new HRMY 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the HRMY quote page for the session range and the stock page for the full model.
Not investment advice.